Chris Lowe

Head of Technology & Innovation at Revvity

Chris Lowe is a seasoned business leader in the biotechnology sector who currently serves as the Head of Technology & Innovation and Site Leader at Revvity in Cambridge, UK.2 3 He has over 20 years of experience in the Cambridge biotech industry.1

Career at Revvity

Chris joined Revvity in 2023 when the company emerged from the life sciences and diagnostics business of PerkinElmer.1 Prior to this, he had been with Horizon Discovery for 12 years, which was acquired by PerkinElmer in 2020 and subsequently became part of Revvity.1 In his current role, Chris is responsible for overseeing Revvity's Scientific Centre of Excellence for Genomic Insight in Cambridge, which was established in July 2023.1

Expertise and Responsibilities

As the Site Leader and Head of Technology & Innovation, Chris plays a crucial role in:

Managing the complex operations of Revvity's Cambridge site
Overseeing the implementation of cutting-edge technologies and equipment
Aligning the Cambridge site's capabilities with Revvity's global network
Focusing on delivering solutions for complex customer problems in the life sciences and diagnostics sectors1

Vision and Approach

Chris is enthusiastic about Revvity's mission to improve human health, which aligns closely with Horizon Discovery's legacy goals.1 He emphasizes the importance of strengthening internal networks among different Revvity sites to maximize the company's capabilities and deliver comprehensive solutions to customers.1

Chris Lowe's extensive experience in the Cambridge biotech scene, combined with his leadership role at Revvity, positions him as a key figure in the company's efforts to advance precision medicine and healthcare technologies.

Highlights

Apr 29 · biotechniques.com

Revvity: New Site Launches in Cambridge - BioTechniques

Jul 21 · technologynetworks.com

Failing Faster To Succeed Sooner in Drug Discovery

Jul 20 · cambridgeindependent.co.uk

Revvity Cambridge showcases demonstration lab at opening of ...

Experience

Head of Technology & Innovation at Revvity

Director at Avvinity Therapeutics (Feb 2019 - Present), Head of Technology & Innovation at Horizon Discovery (Dec 2021 - May 2023), Head of Research Operations at Horizon Discovery (Jan 2017 - Dec 2021), R&D Director at Horizon Discovery (Sep 2013 - Jan 2017), Associate Director at Horizon Discovery (Mar 2013 - Sep 2013), Group Leader at Horizon Discovery (Apr 2011 - Mar 2013), Research Associate at University of Cambridge (Mar 2008 - Apr 2011), Research Scientist at University of Cambridge (Jan 2001 - Mar 2008), Plant Molecular Biologist at NIAB (Oct 1999 - Jan 2001), Assistant Scientific Officer at NIAB (Jul 1997 - Oct 1999)

Education

Executive MBA at University of Cambridge - Judge Business School (2018 - 2020), PhD in Medical Genetics at University of Cambridge (2004 - 2008), Bachelor’s Degree in Molecular Biology and Biotechnology at The University of Hull (1993 - 1996)